Unexpected Adverse Events of Immune Checkpoint Inhibitors

por Shalata, Walid, Yakobson, Alexander, Cohen, Aharon Y., Goldstein, Iris, Saleh, Omar Abu, Dudnik, Yulia, Rouvinov, Keren
Publicado 2023

Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors

por Yakobson, Alexander, Rouvinov, Keren, Cohen, Aharon Y., Goldstein, Iris, Abu Saleh, Omar, Solomon, Adam, Dudnik, Yulia, Shalata, Walid
Publicado 2023

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases

por Goldstein, Iris M, Roisman, Laila C, Keren-Rosenberg, Shoshana, Dudnik, Julia, Nechushtan, Hovav, Shelef, Ilan, Fuchs, Vered, Kian, Waleed, Peled, Nir
Publicado 2020

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

por Peled, Nir, Kian, Waleed, Inbar, Edna, Goldstein, Iris M, Zemel, Melanie, Rotem, Ofer, Rozenblum, Anna B, Nechushtan, Hovav, Dudnik, Elizabeth, Levin, Daniel, Zer, Alona, Keren-Rosenberg, Shoshana, Yust-Katz, Shlomit, Fuchs, Vered, Remilah, Areen A, Shelef, Ilan, Roisman, Laila C
Publicado 2021